These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 16733000

  • 1. Case report: symptomatic oral herpes simplex virus type 2 and asymptomatic genital shedding.
    Olin L, Wald A.
    Herpes; 2006 May; 13(1):25-6. PubMed ID: 16733000
    [Abstract] [Full Text] [Related]

  • 2. Genital shedding of herpes simplex virus among men.
    Wald A, Zeh J, Selke S, Warren T, Ashley R, Corey L.
    J Infect Dis; 2002 Oct 15; 186 Suppl 1():S34-9. PubMed ID: 12353185
    [Abstract] [Full Text] [Related]

  • 3. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.
    Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R, Krieger JN, Corey L.
    N Engl J Med; 2000 Mar 23; 342(12):844-50. PubMed ID: 10727588
    [Abstract] [Full Text] [Related]

  • 4. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA.
    Sex Transm Dis; 2008 Mar 23; 35(3):286-90. PubMed ID: 18157071
    [Abstract] [Full Text] [Related]

  • 5. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.
    Krone MR, Wald A, Tabet SR, Paradise M, Corey L, Celum CL.
    Clin Infect Dis; 2000 Feb 23; 30(2):261-7. PubMed ID: 10671325
    [Abstract] [Full Text] [Related]

  • 6. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB, Drolette L, Koelle DM, Almekinder J, Warren T, Tyring S, Wald A.
    Sex Transm Dis; 2008 Apr 23; 35(4):383-6. PubMed ID: 18362859
    [Abstract] [Full Text] [Related]

  • 7. Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men.
    Kim HN, Meier A, Huang ML, Kuntz S, Selke S, Celum C, Corey L, Wald A.
    J Infect Dis; 2006 Aug 15; 194(4):420-7. PubMed ID: 16845624
    [Abstract] [Full Text] [Related]

  • 8. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R, Wald A, Krantz E, Selke S, Warren T, Vargas-Cortes M, Miller G, Corey L.
    J Infect Dis; 2004 Oct 15; 190(8):1374-81. PubMed ID: 15378428
    [Abstract] [Full Text] [Related]

  • 9. [Recurrent genital herpes].
    Holub M, Labská K, Roubalová K.
    Klin Mikrobiol Infekc Lek; 2008 Apr 15; 14(2):52-9. PubMed ID: 18756434
    [Abstract] [Full Text] [Related]

  • 10. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
    Bollen LJ, Whitehead SJ, Mock PA, Leelawiwat W, Asavapiriyanont S, Chalermchockchareonkit A, Vanprapar N, Chotpitayasunondh T, McNicholl JM, Tappero JW, Shaffer N, Chuachoowong R.
    AIDS; 2008 Jun 19; 22(10):1169-76. PubMed ID: 18525263
    [Abstract] [Full Text] [Related]

  • 11. HSV shedding.
    Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ.
    Antiviral Res; 2004 Aug 19; 63 Suppl 1():S19-26. PubMed ID: 15450382
    [Abstract] [Full Text] [Related]

  • 12. Clinical aspects of recurrent oral herpes simplex virus infection.
    Glick M.
    Compend Contin Educ Dent; 2002 Jul 19; 23(7 Suppl 2):4-8. PubMed ID: 12789980
    [Abstract] [Full Text] [Related]

  • 13. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
    Mark KE, Corey L, Meng TC, Magaret AS, Huang ML, Selke S, Slade HB, Tyring SK, Warren T, Sacks SL, Leone P, Bergland VA, Wald A.
    J Infect Dis; 2007 May 01; 195(9):1324-31. PubMed ID: 17397003
    [Abstract] [Full Text] [Related]

  • 14. [Meningoradiculitis caused by herpes simplex virus type 2].
    Bollen AE, Venema AW, Veldkamp KE.
    Ned Tijdschr Geneeskd; 2007 Oct 27; 151(43):2400-4. PubMed ID: 18019219
    [Abstract] [Full Text] [Related]

  • 15. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
    Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts SW, Sanchez PJ, Wendel GD.
    Obstet Gynecol; 2006 Jul 27; 108(1):141-7. PubMed ID: 16816068
    [Abstract] [Full Text] [Related]

  • 16. Recurrent herpes simplex virus type 2 meningitis: a case report of Mollaret's meningitis.
    Kojima Y, Hashiguchi H, Hashimoto T, Tsuji S, Shoji H, Kazuyama Y.
    Jpn J Infect Dis; 2002 Jun 27; 55(3):85-8. PubMed ID: 12195049
    [Abstract] [Full Text] [Related]

  • 17. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN, Wald A, Harris J, Almekinder J, Heitman C, Corey L.
    Sex Transm Dis; 2008 Feb 27; 35(2):124-8. PubMed ID: 17921912
    [Abstract] [Full Text] [Related]

  • 18. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH, Warren TJ, Justus SE, Heitman CK, HS2100275 STUDY TEAM.
    Sex Transm Dis; 2008 Jul 27; 35(7):668-73. PubMed ID: 18461016
    [Abstract] [Full Text] [Related]

  • 19. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P.
    Curr Med Res Opin; 2005 Oct 27; 21(10):1577-82. PubMed ID: 16238897
    [Abstract] [Full Text] [Related]

  • 20. Prevention of herpes simplex virus type 2 transmission with antiviral therapy.
    Corey L, Ashley R, Valaciclovir HSV Transmission Study Group.
    Herpes; 2004 Aug 27; 11 Suppl 3():170A-174A. PubMed ID: 15319087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.